Athens Research & Technology, Inc. Announces Name Change to Athens Bioscience, Inc.
Athens Research & Technology, Inc., a leading manufacturer of high-purity native human and animal proteins, today announced that it will officially change its corporate name to Athens Bioscience, Inc., effective April 6, 2026.
This name change represents a significant milestone in the company’s evolution from a specialized protein manufacturer into a global bioscience partner serving the diagnostic, research, and biopharmaceutical industries. The new identity, Athens Bioscience, reflects the company’s broadened scope, expanding portfolio, and unwavering commitment to advancing scientific discovery and innovation.
“This transition marks more than a new name, it marks the next chapter in our company’s story,” said John Mitchell, Chief Executive Officer of Athens Research and Technology. “For over 40 years, Athens Research & Technology has been synonymous with quality, reliability, and scientific rigor. As Athens Bioscience, we honor that legacy while embracing a broader mission: to empower discovery through bioscience innovation, transparency, and excellence in everything we do.”
The company emphasized that this is a name change only. Ownership, leadership, and operations remain unchanged, and there will be no disruption to the products, services, or relationships customers rely on. Beginning April 6, 2026, all business correspondence, invoices, and payments should reference the company’s new name:
New Company Name: Athens Bioscience, Inc.
Physical Address: 110 Trans Tech Drive, Athens, GA 30601
Mailing Address: PO Box 80785, Athens, GA 30608-0785
Phone: +1 706-546-0207
Email: marketing@athensbioscience.com
Website: www.athensbioscience.com
All existing @athensresearch.com email addresses will remain active for at least 12 months following the transition to ensure seamless communication. The company’s tax identification number and operations remain the same.
###
Founded in 1986 and headquartered in Athens, Georgia, Athens Bioscience (formerly Athens Research & Technology) is a global manufacturer of high-purity native human and animal proteins serving the research, diagnostic, and cell culture media markets. The company’s high-quality proteins are validated by advanced analytical methods including SDS-PAGE, densitometry, and LC-MS, and produced under ISO 9001:2015-certified quality systems. Its Immunogen Grade program sets a new benchmark in mass-spectrometry-verified purity, reinforcing the company’s mission to deliver unmatched transparency and reliability in bioscience manufacturing.
